SCHEMBL3466652

SCHEMBL3466652

COC(=O)C(CCCc1ccccc1)CCc1ccc(-c2ccccc2F)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.52
MMP3 P08254 1/20 0.52
ALDH1A1 P00352 2/20 0.47
MAPT P10636 2/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
CYP3A4 P08684 1/20 0.47
TSHR P16473 1/20 0.47
MAPKAPK2 P49137 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PPARG P37231 1/20 0.46
PPARA Q07869 1/20 0.46
GRIA4 P48058 1/20 0.46
FFAR1 O14842 1/20 0.43
MME P08473 2/20 0.43
HCAR2 Q8TDS4 1/20 0.43
POLB P06746 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
MMP12 P39900 1/20 0.41
LPAR1 Q92633 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3466571 0.87 MMP2 (0.48) MMP2MMP3ALDH1A1KMT2AMEN1
SCHEMBL7923945 0.87 MMP2 (0.57) MMP2MMP3ALDH1A1MAPTKMT2A
SCHEMBL1860059 0.86 MMP12 (0.53) MMP2MMP3MMEMMP12
SCHEMBL3466555 0.86 LPAR1 (0.50) KMT2AMEN1PPARGPPARAFFAR1
SCHEMBL3466649 0.85 SLC13A5 (0.48) MMP2MMP3ALDH1A1MAPTSMN1; SMN2
SCHEMBL1859940 0.85 GRIK1 (0.51) MMP2MMP3KMT2ATSHRSMN1; SMN2
SCHEMBL1858600 0.82 GRIK1 (0.54) MMP2MMP3KMT2ASMN1; SMN2POLB
SCHEMBL3467613 0.82 PPARA (0.50) MMP2MMP3PPARGPPARAMME
SCHEMBL3467360 0.82 ALDH1A1 (0.54) MMP2MMP3ALDH1A1KMT2AMEN1
SCHEMBL3466739 0.82 MMP2 (0.52) MMP2MMP3PPARGMMEHCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO claimed
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed